472 related articles for article (PubMed ID: 25982720)
1. Defibrillator implantations for primary prevention in the United States: Inappropriate care or inadequate documentation: Insights from the National Cardiovascular Data ICD Registry.
Kaiser DW; Tsai V; Heidenreich PA; Goldstein MK; Wang Y; Curtis J; Turakhia MP;
Heart Rhythm; 2015 Oct; 12(10):2086-93. PubMed ID: 25982720
[TBL] [Abstract][Full Text] [Related]
2. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
[TBL] [Abstract][Full Text] [Related]
3. Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria?
Daugherty SL; Peterson PN; Wang Y; Curtis JP; Heidenreich PA; Lindenfeld J; Vidaillet HJ; Masoudi FA;
Am Heart J; 2009 Aug; 158(2):224-9. PubMed ID: 19619698
[TBL] [Abstract][Full Text] [Related]
4. Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials.
Al-Khatib SM; Hellkamp A; Bardy GH; Hammill S; Hall WJ; Mark DB; Anstrom KJ; Curtis J; Al-Khalidi H; Curtis LH; Heidenreich P; Peterson ED; Sanders G; Clapp-Channing N; Lee KL; Moss AJ
JAMA; 2013 Jan; 309(1):55-62. PubMed ID: 23280225
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
[TBL] [Abstract][Full Text] [Related]
6. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
[TBL] [Abstract][Full Text] [Related]
8. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials.
Hess PL; Al-Khatib SM; Han JY; Edwards R; Bardy GH; Bigger JT; Buxton A; Cappato R; Dorian P; Hallstrom A; Kadish AH; Kudenchuk PJ; Lee KL; Mark DB; Moss AJ; Steinman R; Inoue LY; Sanders G
Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2):179-86. PubMed ID: 25669833
[TBL] [Abstract][Full Text] [Related]
9. Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes.
Sharma A; Al-Khatib SM; Ezekowitz JA; Cooper LB; Fordyce CB; Michael Felker G; Bardy GH; Poole JE; Thomas Bigger J; Buxton AE; Moss AJ; Friedman DJ; Lee KL; Steinman R; Dorian P; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Peterson ED; Inoue LYT; Sanders GD
Eur J Heart Fail; 2018 Jun; 20(6):1031-1038. PubMed ID: 29761861
[TBL] [Abstract][Full Text] [Related]
10. Indication to cardioverter-defibrillator therapy and outcome in real world primary prevention. Data from the IRIDE [Italian registry of prophylactic implantation of defibrillators] study.
Proclemer A; Muser D; Campana A; Zoni-Berisso M; Zecchin M; Locatelli A; Brieda M; Gramegna L; Santarone M; Chiodi L; Mazzone P; Rebellato L; Facchin D
Int J Cardiol; 2013 Sep; 168(2):1416-21. PubMed ID: 23287697
[TBL] [Abstract][Full Text] [Related]
11. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.
Fudim M; Ali-Ahmed F; Parzynski CS; Ambrosy AP; Friedman DJ; Pokorney SD; Curtis JP; Fonarow GC; Masoudi FA; Hernandez AF; Al-Khatib SM
JAMA Cardiol; 2020 Jun; 5(6):643-651. PubMed ID: 32211811
[TBL] [Abstract][Full Text] [Related]
12. Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR).
Russo AM; Daugherty SL; Masoudi FA; Wang Y; Curtis J; Lampert R
Am Heart J; 2015 Aug; 170(2):330-8. PubMed ID: 26299231
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Outcomes Associated With Non-Evidence-Based Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries (From the National Cardiovascular Data Registry).
Daimee UA; Aslam F; Parzynski CS; Desai NR; Curtis JP
Am J Cardiol; 2021 Sep; 155():64-71. PubMed ID: 34315569
[TBL] [Abstract][Full Text] [Related]
14. Patient barriers to implantable cardioverter defibrillator implantation for the primary prevention of sudden cardiac death in patients with heart failure and reduced ejection fraction.
Chan LL; Lim CP; Aung ST; Quetua P; Ho KL; Chong D; Teo WS; Sim D; Ching CK
Singapore Med J; 2016 Apr; 57(4):182-7. PubMed ID: 27075476
[TBL] [Abstract][Full Text] [Related]
15. Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study.
Pun PH; Hellkamp AS; Sanders GD; Middleton JP; Hammill SC; Al-Khalidi HR; Curtis LH; Fonarow GC; Al-Khatib SM
Nephrol Dial Transplant; 2015 May; 30(5):829-35. PubMed ID: 25404241
[TBL] [Abstract][Full Text] [Related]
16. A validated risk model for 1-year mortality after primary prevention implantable cardioverter defibrillator placement.
Heidenreich PA; Tsai V; Curtis J; Wang Y; Turakhia MP; Masoudi FA; Varosy PD; Goldstein MK
Am Heart J; 2015 Aug; 170(2):281-289.e2. PubMed ID: 26299225
[TBL] [Abstract][Full Text] [Related]
17. Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: A report from the National Cardiovascular Data Registry.
Kipp R; Hsu JC; Freeman J; Curtis J; Bao H; Hoffmayer KS
Heart Rhythm; 2018 Jun; 15(6):847-854. PubMed ID: 28987459
[TBL] [Abstract][Full Text] [Related]
18. Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
Bilchick KC; Wang Y; Cheng A; Curtis JP; Dharmarajan K; Stukenborg GJ; Shadman R; Anand I; Lund LH; Dahlström U; Sartipy U; Maggioni A; Swedberg K; O'Conner C; Levy WC
J Am Coll Cardiol; 2017 May; 69(21):2606-2618. PubMed ID: 28545633
[TBL] [Abstract][Full Text] [Related]
19. Implantable Cardioverter-Defibrillator Placement for Primary Prevention in 2,346 Patients: Predictors of One-Year Survival.
Merchant FM; Desai Y; Addish MA; Kelly K; Casey M; Goyal A; Leon AR; El-Chami MF
Tex Heart Inst J; 2018 Aug; 45(4):221-225. PubMed ID: 30374229
[TBL] [Abstract][Full Text] [Related]
20. Regional variation in the use of implantable cardioverter-defibrillators for primary prevention: results from the National Cardiovascular Data Registry.
Matlock DD; Peterson PN; Heidenreich PA; Lucas FL; Malenka DJ; Wang Y; Curtis JP; Kutner JS; Fisher ES; Masoudi FA
Circ Cardiovasc Qual Outcomes; 2011 Jan; 4(1):114-21. PubMed ID: 21139094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
